Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | DDO |
Upstream (Parents) |
---|
(<<) HMGCL → DDO |
(<<) CYP4F2///CYP4F3 → DDO |
(<<) ALDH3A2 → DDO |
(<<) SLC7A9 → DDO |
Downstream (Children) |
---|
DDO → C18orf22 (>>) |
DDO → MAST2 (>>) |
DDO → REG1B (>>) |
DDO → OR1A2 (>>) |